Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 04, 2017 08:41 ET | Source: Diffusion Pharmaceuticals, Inc.

Diffusion Pharmaceuticals Awarded U.S. Patent for TSC as Therapeutic in Five Hypoxia-Related Indications

CHARLOTTESVILLE, Va., April 04, 2017 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN), a clinical stage biotechnology company focused on the development of novel small molecule...
April 03, 2017 08:30 ET | Source: Diffusion Pharmaceuticals, Inc.

Diffusion Pharmaceuticals Announces Closing of Oversubscribed Private Placement

CHARLOTTESVILLE, Va., April 03, 2017 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN), a clinical stage biotechnology company focused on the development of novel small molecule...
March 31, 2017 08:30 ET | Source: Diffusion Pharmaceuticals, Inc.

Diffusion Pharmaceuticals Provides Corporate Highlights and Reports 2016 Financial Results

CHARLOTTESVILLE, Va., March 31, 2017 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN), a clinical stage biotechnology company focused on the development of novel small molecule...
February 08, 2017 08:00 ET | Source: Diffusion Pharmaceuticals, Inc.

Diffusion Pharmaceuticals’ TSC Phase 1/2 Glioblastoma Multiforme Clinical Trial Results Published in February 2017 Edition of Journal of Neurosurgery

CHARLOTTESVILLE, Va., Feb. 08, 2017 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN), a clinical stage biotechnology company focused on the development of novel small molecule...
December 12, 2016 08:30 ET | Source: Diffusion Pharmaceuticals, Inc.

Diffusion Pharmaceuticals Files Definitive Proxy Statement for Upcoming Special Meeting of Stockholders

CHARLOTTESVILLE, Va., Dec. 12, 2016 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN), a clinical stage biotechnology company focused on the development of novel small molecule...
November 14, 2016 08:00 ET | Source: Diffusion Pharmaceuticals, Inc.

Diffusion Pharmaceuticals Provides Corporate Highlights and Reports Financial Third Quarter 2016 Results

CHARLOTTESVILLE, Va., Nov. 14, 2016 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN), a clinical stage biotechnology company focused on the development of novel small molecule...
November 08, 2016 08:00 ET | Source: Diffusion Pharmaceuticals, Inc.

Diffusion Pharmaceuticals Announces Uplisting to NASDAQ Capital Market

CHARLOTTESVILLE, Va., Nov. 08, 2016 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (OTCQX:DFFN), a clinical stage biotechnology company focused on the development of novel small molecule...
September 29, 2016 10:05 ET | Source: Diffusion Pharmaceuticals, Inc.

Diffusion Pharmaceuticals Establishes Scientific Advisory Board

CHARLOTTESVILLE, Va., Sept. 29, 2016 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (OTCQX:DFFN), a clinical stage biotechnology company focused on the development of novel small molecule...
September 19, 2016 08:30 ET | Source: Diffusion Pharmaceuticals, Inc.

Diffusion Pharmaceuticals Successfully Completes Animal Toxicity Studies in Preparation for Phase 3 Pivotal Trial of TSC in New Diagnosed Glioblastoma Patients

CHARLOTTESVILLE, Va., Sept. 19, 2016 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (OTCQX:DFFN), a clinical stage biotechnology company focused on the development of novel small molecule...
September 09, 2016 08:30 ET | Source: Diffusion Pharmaceuticals, Inc.

Diffusion Pharmaceuticals to Present at 18th Annual Rodman & Renshaw Global Investment Conference

CHARLOTTESVILLE, Va., Sept. 09, 2016 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (OTCQX:DFFND), a clinical stage biotechnology company focused on the development of novel small molecule...